HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Curtil, A. Articles by Champsaur, G. Search for Related Content PubMed PubMed Citation Articles by Curtil, A. Articles by Champsaur, G.

European Journal of Cardio-Thoracic Surgery, Vol 12, 101-106, Copyright © 1997 by European Association for Cardio-thoracic Surgery

ARTICLES

Malignant neoplasms following cardiac transplantation

A Curtil, J Robin, F Tronc, J Ninet, P Boissonnat and G Champsaur
Service de Chirurgie Thoracique et Cardiovasculaire C, Louis Pradel Cardiovascular Hospital, Lyon, France. gerard.champsaur@univ-lyon1.fr

OBJECTIVE: Malignancies have long been recognized as a complication of long lasting immunosuppressive therapy. We reviewed our experience to investigate the incidence and the spectrum of non cutaneous de novo malignant neoplasms. METHODS: Between March 1987 and March 1996, 296 patients underwent 303 cardiac transplantation in our service. The population at risk consists of all patients surviving more than 1 month after transplantation, leading to a total of 267 patients. A triple- immunosuppressive therapy was employed. Moderate doses of antilymphocyte globulin was used as an induction immunotherapy. RESULTS: Neoplasms developed in 18 (6.7%) of the 267 patients at risk. Seventeen patients were male. Mean age was 56 +/- 7 years. Fourteen patients (78%) reported a significant smoking history. Mean interval between transplantation and clinical diagnosis was 36 months. Lung neoplasms (especially adenocarcinoma) were the most commonly encountered tumors (11 of 268 patients, 4.1%). Three Non-Hodgkins' Lymphoma (NHL) were identified (1.1%). No Kaposi's sarcoma were diagnosed. Mean survival after a diagnostic of tumor was 11.7 months. CONCLUSIONS: The incidence of NHL is low in our transplant recipients. Conversely, we observed a high incidence of lung neoplasms (especially adenocarcinoma) which can be correlated with a heavy cigarette use in the study population.

This article has been cited by other articles:

				K. Potaris, B. Radovancevic, C. D. Thomas, I. Gregoric, A. A. Vaporciyan, S. A. Riggs, R. Radovancevic, W. K. Vaughn, and O.H. Frazier Lung Cancer After Heart Transplantation: A 17-Year Experience Ann. Thorac. Surg., March 1, 2005; 79(3): 980 - 983. [Abstract] [Full Text] [PDF]

				P. Bagan, J. Assouad, P. Berna, R. Souilamas, F. Le Pimpec Barthes, and M. Riquet Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Ann. Thorac. Surg., February 1, 2005; 79(2): 438 - 442. [Abstract] [Full Text] [PDF]

				Z. Ahmed, M. B. Marshall, J. C. Kucharczuk, L. R. Kaiser, and J. B. Shrager Lung Cancer in Transplant Recipients: A Single-Institution Experience Arch Surg, August 1, 2004; 139(8): 902 - 906. [Abstract] [Full Text] [PDF]

				M. de Perrot, D. A. Wigle, A. F. Pierre, M. S. Tsao, T. K. Waddell, T. R.J. Todd, and S. H. Keshavjee Bronchogenic carcinoma after solid organ transplantation Ann. Thorac. Surg., February 1, 2003; 75(2): 367 - 371. [Abstract] [Full Text] [PDF]